Director

Glenn P. Muir

Director·Repligen Corp.

About

Glenn P. Muir has served as a director of Repligen since October 2015. Mr. Muir brings over 30 years of experience to the director role, including 26 years with Hologic, Inc., a large multi-national medical device and diagnostics company where he most recently served as CFO and Executive Vice President. Mr. Muir retired in May 2014 from Hologic, where he helped steer the company's evolution from a venture-backed single product company to a publicly-traded diversified organization with over 5,000 employees and $2.5 billion in revenue. He joined Hologic in 1988 and served as CFO since 1992 and Executive Vice President since 2000.

Prior to Hologic, Mr. Muir was with Metallon Engineered Materials Co., a private company where, from 1986 to 1988 he held the role of Vice President, Finance. Previously, from 1981 to 1984, he was a Senior Auditor with Arthur Andersen & Co.

Mr. Muir is a Certified Public Accountant (inactive since 2022) with a B.A. from the University of Massachusetts, Amherst. He also earned a M.S. in Taxation from Bentley University and a M.B.A. from Harvard University.

Since 2015
Age 67
Tenure 11 yrs

Also at Repligen Corp.

OL Olivier Loeillot President and Chief Executive Officer, Director MM Martin D. Madaus Director, Chair of the Board KD Karen A. Dawes Director NB Nicolas M. Barthelemy Director CM Carrie Eglinton Manner Director KK Konstantin Konstantinov Director

Roles

Organization Role Dates Details
Repligen Corp. Director 2015–present Current role
Hologic, Inc. Chief Financial Officer and Executive Vice President 1988-2014 26 years with Hologic; joined 1988, CFO since 1992, EVP since 2000; retired May 2014. Helped steer evolution to a publicly-traded organization with over 5,000 employees and $2.5 billion in revenue.
Metallon Engineered Materials Co. Vice President, Finance 1986-1988 Private company.
Arthur Andersen & Co. Senior Auditor 1981-1984

External roles

Organization Role Dates
Neuronetics, Inc. Director
G1 Therapeutics, Inc. Director (former) 2015-2024
ReWalk Robotics Ltd. Director (former) 2014-2017

Related

Source: Repligen Corp. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo